Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00890747
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:32.162854+00:00
Published At
2014-03-17T00:00:00+00:00
Record Updated At
2014-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Accelerated Phase Chronic Myelogenous Leukemia", "Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome", "Acute Undifferentiated Leukemia", "Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Grade III Lymphomatoid Granulomatosis", "Adult Langerhans Cell Histiocytosis", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Aggressive NK-cell Leukemia", "AIDS-related Diffuse Large Cell Lymphoma", "AIDS-related Diffuse Mixed Cell Lymphoma", "AIDS-related Diffuse Small Cleaved Cell Lymphoma", "AIDS-related Immunoblastic Large Cell Lymphoma", "AIDS-related Lymphoblastic Lymphoma", "AIDS-related Malignancies", "AIDS-related Small Noncleaved Cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "Chronic Eosinophilic Leukemia", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia", "Clear Cell Renal Cell Carcinoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "de Novo Myelodysplastic Syndromes", "Essential Thrombocythemia", "Extramedullary Plasmacytoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Hepatosplenic T-cell Lymphoma", "HIV Infection", "HIV-associated Hodgkin Lymphoma", "Intraocular Lymphoma", "Isolated Plasmacytoma of Bone", "Light Chain Deposition Disease", "Mast Cell Leukemia", "Myelodysplastic Syndrome With Isolated Del(5q)", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Myeloid/NK-cell Acute Leukemia", "Nodal Marginal Zone B-cell Lymphoma", "Noncutaneous Extranodal Lymphoma", "Osteolytic Lesions of Multiple Myeloma", "Peripheral T-cell Lymphoma", "Plasma Cell Neoplasm", "Polycythemia Vera", "Post-transplant Lymphoproliferative Disorder", "Previously Treated Myelodysplastic Syndromes", "Primary Myelofibrosis", "Primary Systemic Amyloidosis", "Progressive Hairy Cell Leukemia, Initial Treatment", "Prolymphocytic Leukemia", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Adult T-cell Leukemia/Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Renal Cell Cancer", "Recurrent Small Lymphocytic Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Stage IV Renal Cell Cancer", "T-cell Large Granular Lymphocyte Leukemia", "Testicular Lymphoma", "Unspecified Adult Solid Tumor, Protocol Specific", "Waldenstr\u00f6m Macroglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-03-17"
protocolSection.identificationModule.nctId
"NCT00890747"
protocolSection.identificationModule.officialTitle
"A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Accelerated Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Acute Undifferentiated Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Del(5q) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) (protocolSection.conditionsModule.conditions)
  • Adult Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • Adult Langerhans Cell Histiocytosis (protocolSection.conditionsModule.conditions)
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Aggressive NK-cell Leukemia (protocolSection.conditionsModule.conditions)
  • AIDS-related Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Malignancies (protocolSection.conditionsModule.conditions)
  • AIDS-related Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative (protocolSection.conditionsModule.conditions)
  • Chronic Eosinophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Neutrophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Clear Cell Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Cutaneous B-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • de Novo Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Essential Thrombocythemia (protocolSection.conditionsModule.conditions)
  • Extramedullary Plasmacytoma (protocolSection.conditionsModule.conditions)
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (protocolSection.conditionsModule.conditions)
  • Hepatosplenic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • HIV Infection (protocolSection.conditionsModule.conditions)
  • HIV-associated Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Intraocular Lymphoma (protocolSection.conditionsModule.conditions)
  • Isolated Plasmacytoma of Bone (protocolSection.conditionsModule.conditions)
  • Light Chain Deposition Disease (protocolSection.conditionsModule.conditions)
  • Mast Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome With Isolated Del(5q) (protocolSection.conditionsModule.conditions)
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable (protocolSection.conditionsModule.conditions)
  • Myeloid/NK-cell Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Nodal Marginal Zone B-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncutaneous Extranodal Lymphoma (protocolSection.conditionsModule.conditions)
  • Osteolytic Lesions of Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Peripheral T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Plasma Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Polycythemia Vera (protocolSection.conditionsModule.conditions)
  • Post-transplant Lymphoproliferative Disorder (protocolSection.conditionsModule.conditions)
  • Previously Treated Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Primary Systemic Amyloidosis (protocolSection.conditionsModule.conditions)
  • Progressive Hairy Cell Leukemia, Initial Treatment (protocolSection.conditionsModule.conditions)
  • Prolymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult T-cell Leukemia/Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Recurrent Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Hairy Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Relapsing Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • T-cell Large Granular Lymphocyte Leukemia (protocolSection.conditionsModule.conditions)
  • Testicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Unspecified Adult Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)
  • Waldenström Macroglobulinemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.